These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 34826422)
41. Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma. Hearle N; Damato BE; Humphreys J; Wixey J; Green H; Stone J; Easton DF; Houlston RS Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):458-62. PubMed ID: 12556369 [TBL] [Abstract][Full Text] [Related]
42. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082 [TBL] [Abstract][Full Text] [Related]
43. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma. Furonaka O; Takeshima Y; Awaya H; Ishida H; Kohno N; Inai K Pathol Int; 2004 Aug; 54(8):549-55. PubMed ID: 15260845 [TBL] [Abstract][Full Text] [Related]
44. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status. Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544 [TBL] [Abstract][Full Text] [Related]
45. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221 [TBL] [Abstract][Full Text] [Related]
46. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. van der Avoort IA; Shirango H; Hoevenaars BM; Grefte JM; de Hullu JA; de Wilde PC; Bulten J; Melchers WJ; Massuger LF Int J Gynecol Pathol; 2006 Jan; 25(1):22-9. PubMed ID: 16306780 [TBL] [Abstract][Full Text] [Related]
47. Mutational analysis of N-ras, p53, CDKN2A (p16(INK4a)), p14(ARF), CDK4, and MC1R genes in human dysplastic melanocytic naevi. Papp T; Pemsel H; Rollwitz I; Schipper H; Weiss DG; Schiffmann D; Zimmermann R J Med Genet; 2003 Feb; 40(2):E14. PubMed ID: 12566532 [No Abstract] [Full Text] [Related]
48. p14(ARF) methylation is a common event in the pathogenesis and progression of myxoid and pleomorphic liposarcoma. Davidović R; Sopta J; Mandušić V; Krajnović M; Stanojević M; Tulić G; Dimitrijević B Med Oncol; 2013; 30(3):682. PubMed ID: 23918242 [TBL] [Abstract][Full Text] [Related]
49. Frequent p16-independent inactivation of p14ARF in human melanoma. Freedberg DE; Rigas SH; Russak J; Gai W; Kaplow M; Osman I; Turner F; Randerson-Moor JA; Houghton A; Busam K; Timothy Bishop D; Bastian BC; Newton-Bishop JA; Polsky D J Natl Cancer Inst; 2008 Jun; 100(11):784-95. PubMed ID: 18505964 [TBL] [Abstract][Full Text] [Related]
50. Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status. Xiong J; Epstein RJ Mol Cancer Ther; 2009 Apr; 8(4):779-85. PubMed ID: 19372550 [TBL] [Abstract][Full Text] [Related]
51. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Tachibana I; Smith JS; Sato K; Hosek SM; Kimmel DW; Jenkins RB Am J Med Genet; 2000 May; 92(2):136-41. PubMed ID: 10797439 [TBL] [Abstract][Full Text] [Related]
52. DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients. Bodoor K; Haddad Y; Alkhateeb A; Al-Abbadi A; Dowairi M; Magableh A; Bsoul N; Ghabkari A Asian Pac J Cancer Prev; 2014; 15(1):75-84. PubMed ID: 24528084 [TBL] [Abstract][Full Text] [Related]
53. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465 [TBL] [Abstract][Full Text] [Related]
54. p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors. Venneti S; Le P; Martinez D; Eaton KW; Shyam N; Jordan-Sciutto KL; Pawel B; Biegel JA; Judkins AR J Neuropathol Exp Neurol; 2011 Jul; 70(7):596-609. PubMed ID: 21666498 [TBL] [Abstract][Full Text] [Related]
55. Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression. Watanabe T; Katayama Y; Yoshino A; Yachi K; Ohta T; Ogino A; Komine C; Fukushima T Brain Pathol; 2007 Jan; 17(1):5-10. PubMed ID: 17493032 [TBL] [Abstract][Full Text] [Related]
56. Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma. Xiaofang L; Kun T; Shaoping Y; Zaiqiu W; Hailong S World J Surg Oncol; 2012 Jan; 10():5. PubMed ID: 22230750 [TBL] [Abstract][Full Text] [Related]
57. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes. Wolter M; Reifenberger J; Blaschke B; Ichimura K; Schmidt EE; Collins VP; Reifenberger G J Neuropathol Exp Neurol; 2001 Dec; 60(12):1170-80. PubMed ID: 11764089 [TBL] [Abstract][Full Text] [Related]
58. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma. Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901 [TBL] [Abstract][Full Text] [Related]
59. p16INK⁴a and p14ARF mRNA expression in Pap smears is age-related. von Keyserling H; Kühn W; Schneider A; Bergmann T; Kaufmann AM Mod Pathol; 2012 Mar; 25(3):465-70. PubMed ID: 22080060 [TBL] [Abstract][Full Text] [Related]
60. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer. Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]